Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIL Therapy with Immunomodulation for Advanced Melanoma
NCT00002535Phase 2Completed
- Sponsor
- St. Luke's Medical Center
- Start
- Jul 1993
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic tumor-infiltrating lymphocytes in melanoma, sponsored by St. Luke's Medical Center. Started Jul 1993; status: completed.
02
Drugs
therapeutic tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002535.